Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
AbbVie
(NY:
ABBV
)
93.98
USD
-0.31 (-0.33%)
Streaming Delayed Price
/ Updated:
12:56 PM EDT, Aug 5, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
3,044,903
Open
94.47
Bid (Size)
93.97 (3)
Ask (Size)
93.99 (4)
Prev. Close
94.29
Today's Range
93.69 - 94.80
52wk Range
62.55 - 101.28
Shares Outstanding
1,586,879,451
Dividend Yield
3.82%
Performance
YTD
+4.95%
+4.95%
1 Month
-5.08%
-5.08%
3 Month
+10.09%
+10.09%
6 Month
+11.40%
+11.40%
1 Year
+44.07%
+44.07%
Top News
More News
Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial
August 03, 2020
- I-SPY COVID will evaluate the impact of cenicriviroc, Otezla®, and Firazyr® on inflammatory response in COVID-19 patients
Read More
from
PR Newswire
Yearly US Gainers With Bullish Signs: $ABBV $KHC $ORCL
August 04, 2020
category
The Market Signal
from
The Market Signal
More News
Read More
AbbVie Reports Second-Quarter 2020 Financial Results
July 31, 2020
from
PR Newswire
AbbVie Announces Positive Phase 3 Data for Atogepant in Migraine Prevention
July 29, 2020
from
PR Newswire
Third Pivotal Phase 3 Study Shows RINVOQ™ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients
July 28, 2020
from
PR Newswire
Noteworthy Friday Option Activity: IBM, ABBV, F
July 31, 2020
category
Stocks
from
Market News Video
How Neurocrine Biosciences Crushed It in Q2
August 04, 2020
category
ABBV
,
NBIX
,
Market News
, and 1 more.
from
Motley Fool
2 Stocks to Supplement Your Social Security Income
August 02, 2020
category
ABBV
,
Market News
,
MRNA
, and 5 more.
from
Motley Fool
AbbVie (ABBV) Q2 2020 Earnings Call Transcript
July 31, 2020
category
Market News
,
ABBV
from
Motley Fool
A Preview Of AbbVie's Earnings
July 30, 2020
category
Benzinga
,
Market News
,
Earnings
, and 1 more.
from
Benzinga
5 Key Things You'll Want to Know About AbbVie's Q2 Update
July 31, 2020
category
ABBV
,
Market News
from
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
